These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 406560)

  • 21. [Acute leukemia secondary to the treatment of multiple sclerosis with chlorambucil].
    Aymard JP; Witz F; Conroy T; Lederlin P; Humbert JC; Barroche G; Streiff F
    Rev Neurol (Paris); 1985; 141(2):152-4. PubMed ID: 3858929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary treatment of advanced ovarian adenocarcinoma, stages III and IV.
    Piver S; Barlow JJ; Chung WS; Lee FT; Vongtama V
    Natl Cancer Inst Monogr; 1975 Oct; 42():177-82. PubMed ID: 825780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: Androgen role in erythroleukemia after treatment with alkylating agents.
    Ruffner BW
    Ann Intern Med; 1974 Jul; 81(1):118-9. PubMed ID: 4366293
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.
    Greene MH; Young RC; Merrill JM; DeVita VT
    Cancer Res; 1983 Apr; 43(4):1891-8. PubMed ID: 6572558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukemia after therapy with alkylating agents for childhood cancer.
    Tucker MA; Meadows AT; Boice JD; Stovall M; Oberlin O; Stone BJ; Birch J; Voûte PA; Hoover RN; Fraumeni JF
    J Natl Cancer Inst; 1987 Mar; 78(3):459-64. PubMed ID: 3469460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute leukemia following prolonged cytotoxic agent therapy.
    Casciato DA; Scott JL
    Medicine (Baltimore); 1979 Jan; 58(1):32-47. PubMed ID: 105227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute leukemia after chemotherapy (melphalan).
    Einhorn N
    Cancer; 1978 Feb; 41(2):444-7. PubMed ID: 272946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myeloid leukemia following non-Hodgkin's lymphoma: danger of prolonged use of chlorambucil as maintenance therapy.
    Dumont J; Thiery JP; Mazabraud A; Natali JC; Trapet P; Vilcoq JR
    Nouv Rev Fr Hematol (1978); 1980; 22(4):391-404. PubMed ID: 6942388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer and secondary leukemia.
    Rosner F
    Bull Cancer; 1983; 70(1):55-60. PubMed ID: 6573207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
    Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU).
    Boice JD; Greene MH; Killen JY; Ellenberg SS; Keehn RJ; McFadden E; Chen TT; Fraumeni JF
    N Engl J Med; 1983 Nov; 309(18):1079-84. PubMed ID: 6353233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melphalan may be a more potent leukemogen than cyclophosphamide.
    Greene MH; Harris EL; Gershenson DM; Malkasian GD; Melton LJ; Dembo AJ; Bennett JM; Moloney WC; Boice JD
    Ann Intern Med; 1986 Sep; 105(3):360-7. PubMed ID: 3740675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer.
    Lerner HJ
    Cancer Treat Rep; 1978 Aug; 62(8):1135-8. PubMed ID: 278642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute nonlymphocytic leukemia following bladder instillations with thiotepa.
    Easton DJ; Poon MA
    Can Med Assoc J; 1983 Sep; 129(6):578-9. PubMed ID: 6411320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case-control study of leukaemia as a second primary malignancy following ovarian and breast neoplasms.
    Mehnert WH; Haas JF; Kittelmann B; Staneczek W; Möhner M; Kaldor JM; Day NE
    IARC Sci Publ; 1986; (78):203-21. PubMed ID: 3583391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute leukemia as a complication of long-term treatment of advanced breast cancer.
    Portugal MA; Falkson HC; Stevens K; Falkson G
    Cancer Treat Rep; 1979 Feb; 63(2):177-81. PubMed ID: 286640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pyoderma gangrenosum, ovarian carcinoma treated with Melphalan and acute myelomonocytic leukaemia: report of one case and literature review (author's transl)].
    Ortonne JP; Thivolet J; Chouvet B; Coiffet J
    Ann Dermatol Venereol; 1979 Mar; 106(3):251-6. PubMed ID: 290349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.